Chuanning Biology (301301.SZ) stated on its Investor Interaction Platform on June 7th that the company's overseas sales mainly focus on antibiotic intermediates. Export sales are mainly aimed at overseas pharmaceutical companies and foreign traders, and the majority of the export destinations are India and Hong Kong.
川宁生物(301301.SZ)：公司海外销售以抗生素中间体产品为主
Chuanning Biotechnology (301301.SZ): the company's overseas sales are mainly focused on antibiotic intermediates products.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.